Arcturus Therapeutics Holdings Inc (ARCT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $240.96M
Last updated: Nov 17, 2026 at 11:04 AM ET
Arcturus Therapeutics Holdings Inc (ARCT) Competitors
The companies most similar to Arcturus Therapeutics Holdings are Rocket Pharmaceuticals (RCKT), ARS Pharmaceuticals (SPRY) and ProQR Therapeutics BV (PRQR). By market cap, Arcturus Therapeutics Holdings ranks 5th of the 13 companies on this page; ARS Pharmaceuticals (SPRY) is the largest at $391.06M.
Peer Comparison
ARCT's revenue growth of 6.7% is below the peer median of 18.6%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Arcturus Therapeutics Holdings (ARCT) | $240.96M | N/A | 7.7x | -285.9% | N/A | 6.7% | 0.00% |
| Rocket Pharmaceuticals Inc (RCKT) | $256.82M | N/A | N/A | 0.0% | -2.3% | 0.0% | 0.00% |
| ARS Pharmaceuticals, Inc (SPRY) | $391.06M | N/A | 2.9x | -163.6% | -143.8% | 16.0% | 0.00% |
| ProQR Therapeutics BV (PRQR) | $199.28M | N/A | 6.1x | -228.2% | N/A | 120.4% | 0.00% |
| Entrada Therapeutics Inc (TRDA) | $199.28M | N/A | 53.3x | 0.0% | -69.7% | -43.9% | 0.00% |
| Larimar Therapeutics Inc (LRMR) | $313.73M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Invivyd Inc. (IVVD) | $171.58M | N/A | 2.9x | -183.9% | N/A | 21.2% | 0.00% |
| Protara Therapeutics Inc (TARA) | $155.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Keros Therapeutics Inc (KROS) | $202.13M | N/A | 4.9x | -151.4% | N/A | 180.5% | 0.00% |
| Armata Pharmaceuticals Inc (ARMP) | $143.94M | N/A | 14.7x | 0.0% | -184.6% | 173.6% | 0.00% |
| Prelude Therapeutics Inc (PRLD) | $275.32M | N/A | 16.3x | -269.7% | N/A | 41.0% | 0.00% |
| Bicycle Therapeutics Ltd (BCYC) | $236.22M | N/A | 2.7x | -169.8% | N/A | 190.2% | 0.00% |
| Immuneering Corp (IMRX) | $240.27M | N/A | N/A | 0.0% | N/A | -99.8% | 0.00% |
| Peer median | $219.17M | N/A | 5.5x | -75.7% | -106.8% | 18.6% | 0.00% |
Similar Companies
These are the 12 companies most similar to Arcturus Therapeutics Holdings, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Rocket Pharmaceuticals Inc (RCKT) | Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases. | RCKT competitors |
| ARS Pharmaceuticals, Inc (SPRY) | ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine aerosol with absorption technology for patients and their families at risk of severe... | SPRY competitors |
| ProQR Therapeutics BV (PRQR) | ProQR Therapeutics NV, a biopharmaceutical company, is dedicated to the discovery and development of RNA-based therapies for the treatment of genetic disorders. | PRQR competitors |
| Entrada Therapeutics Inc (TRDA) | Entrada Therapeutics Inc. (TRDA) is a forward-thinking biotechnology company focused on creating innovative therapies for severe diseases characterized by... | TRDA competitors |
| Larimar Therapeutics Inc (LRMR) | Larimar Therapeutics, Inc., a clinical-stage biotechnology company, is focused on developing treatments for rare diseases. | LRMR competitors |
| Invivyd Inc. (IVVD) | Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery... | IVVD competitors |
| Protara Therapeutics Inc (TARA) | Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to identifying and promoting transformative therapies for the treatment... | TARA competitors |
| Keros Therapeutics Inc (KROS) | Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery... | KROS competitors |
| Armata Pharmaceuticals Inc (ARMP) | Armata Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of specific bacteriophage therapies for the treatment... | ARMP competitors |
| Prelude Therapeutics Inc (PRLD) | Prelude Therapeutics Incorporated, a precision clinical-stage oncology company, focuses on the discovery and development of small molecule therapies optimized... | PRLD competitors |
| Bicycle Therapeutics Ltd (BCYC) | Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, is developing a class of drugs for diseases that are not served by existing treatments. | BCYC competitors |
| Immuneering Corp (IMRX) | Immuneering Corp (IMRX) is a cutting-edge biotechnology firm dedicated to advancing targeted therapeutics for cancer and other critical illnesses through its... | IMRX competitors |
Frequently Asked Questions About ARCT
Who are Arcturus Therapeutics Holdings' main competitors?
The companies most similar to Arcturus Therapeutics Holdings include Rocket Pharmaceuticals (RCKT), ARS Pharmaceuticals (SPRY), ProQR Therapeutics BV (PRQR), Entrada Therapeutics (TRDA) and Larimar Therapeutics (LRMR), listed from the closest match.
Who is Arcturus Therapeutics Holdings' biggest competitor?
ARS Pharmaceuticals (SPRY) is the largest of the similar companies at $391.06M; Rocket Pharmaceuticals (RCKT) is the closest match by business profile, size, sector and industry.
How does ARCT stock compare with its competitors?
ARCT's P/S is 7.7x against a peer median of 5.5x; its net margin is -285.9% against a peer median of -75.7%.
Which of Arcturus Therapeutics Holdings' competitors pays a higher dividend?
Arcturus Therapeutics Holdings pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Arcturus Therapeutics Holdings bigger than its competitors?
No. Arcturus Therapeutics Holdings is 5th by market cap among the 13 companies on this page; the largest is ARS Pharmaceuticals (SPRY) at $391.06M.
ARCT pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors